Can a chat with a peer get doctors to prescribe cheaper drugs?
NCT ID NCT07221890
Summary
This study tests if educational visits to doctors change how often they prescribe lower-cost 'biosimilar' versions of a common drug (adalimumab/Humira) for autoimmune diseases. Researchers will compare doctors who receive the educational visit to those who do not, measuring changes in prescription patterns. The study also aims to see if in-person or virtual visits are more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Humana Healthcare Research, Inc.
Louisville, Kentucky, 40202, United States
Conditions
Explore the condition pages connected to this study.